Skip to content

Search

Showing results for "aboriginal respiratory"

Cystic Fibrosis Early Surveillance Program

Researchers are able to track the progress of lung disease through a comprehensive longitudinal set of biological samples, images and data archives.

Chemical analysis of new and “aged” e-liquids: Development of a rapid toxicological screening approach

Alexander Larcombe BScEnv (Hons) PhD Honorary Research Fellow Honorary Research Fellow Associate Professor Alexander Larcombe began work at The Kids

Is acamprosate safe to use in pregnancy, and can it mitigate the effects of alcohol consumption in pregnant mice?

Alexander Larcombe BScEnv (Hons) PhD Honorary Research Fellow Honorary Research Fellow Associate Professor Alexander Larcombe began work at The Kids

KINDEE: Kids INfections and Day care’s Effects on the lungs in those born Early

Over the last 40 years medical advances in the care of newborn babies has resulted in more children surviving very early “preterm” birth than ever before.

Lung function in a model of a paediatric metabolic disease

Alexander Larcombe BScEnv (Hons) PhD Honorary Research Fellow Honorary Research Fellow Associate Professor Alexander Larcombe began work at The Kids

The clinical significance of oropharyngeal cultures in young children with cystic fibrosis

The clinical significance of oropharyngeal cultures in young children with cystic fibrosis ABSTRACT In children with cystic fibrosis (CF) the

Community Involvement

As part of our research development and planning we invite members of the community to work with us. Click here to find out how.

WA Near Miss Awards provide boost for leading researchers at The Kids

Nine researchers from The Kids Research Institute Australia have secured vital support through the WA Near Miss Awards, allowing them to continue innovative health projects that narrowly missed out on national funding.

Nasal spray to prevent ear infections closer to fruition thanks to major grant

A nasal spray that could potentially prevent childhood ear infections and reduce antibiotic use is a step closer to clinical trials thanks to a $500,000 CUREator grant.